Naproxen Caplets Tablet
Product Images NDC 69168-362

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Naproxen Caplets (NDC 69168-362). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allegiant Health, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Naproxen Sodium 220mg (362 Health A2z Naproxen Sodium 220mg 1)

Naproxen Sodium 220mg (362   Health A2z Naproxen Sodium 220mg 1)
This -generated text is a detailed drug information sheet, providing essential details about the usage, dosage, warnings, and active ingredients of a medication containing Naproxen sodium 220mg. It includes directions for use, information on drug interactions, and potential side effects. The document emphasizes the importance of following dosage instructions, avoiding overdose, and seeking medical help in case of allergic reactions or adverse effects. It also contains vital warnings related to stomach bleeding, heart attack, and stroke risks associated with the medication, along with guidance on when to stop use and consult a doctor.*
FDA Label Image

362 Health A2z Naproxen Sodium 220mg 2

362   Health A2z Naproxen Sodium 220mg 2
This is a detailed description of a medication containing Naproxen sodium as the active ingredient, with each caplet containing 220mg of Naproxen sodium. It functions as a pain reliever and fever reducer, providing relief for minor aches and pains such as headaches, arthritis pain, muscular aches, backaches, menstrual cramps, toothaches, and fever associated with the common cold. However, there are warnings provided regarding allergic reactions, stomach bleeding, heart attack, and stroke risks associated with the use of this medication. It is advised to consult a doctor before usage if there is a history of certain conditions. The medication should not be taken in certain situations, especially during the last three months of pregnancy without doctor's approval due to potential risks to the unborn child. The dosage and administration instructions are also provided, with recommendations on when to stop usage and seek medical help. Additionally, there is information on the inactive ingredients, storage instructions, and a disclaimer that clarifies this product is not manufactured or distributed by Bayer HealthCare, LLC, the owner of the registered trademark AleveĀ®. For further inquiries or comments, there is a contact number provided for customer service.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.